Clinical Trials Directory

Trials / Completed

CompletedNCT03722784

Evaluation of Silicone Hydrogel Daily Wear Contact Lenses for Up to One (1) Month of Daily Wear

Evaluation of the CooperVision, Inc. Invigor A and Invigor B Silicone Hydrogel Daily Wear Contact Lenses When Used for Frequent Replacement for Up to One (1) Month of Daily Wear

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
CooperVision, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to evaluate if the performance of Invigor A is substantially equivalent to Invigor B contact lenses when used in a one month recommended replacement, daily wear modality.

Detailed description

This study is a multi-centered, daily wear, monthly replacement, bilateral, randomized in a ratio of two to one (2:1) Test to Control, lens blocked (subjects remain in the same lens brand throughout the study), licensed investigator and subject masked, concurrent controlled study with a study duration of approximately three months evaluating performance equivalence of Invigor A (test) over Invigor B (control) contact lenses.

Conditions

Interventions

TypeNameDescription
DEVICEInvigor A (test)silicone hydrogel lens
DEVICEInvigor B (control)silicone hydrogel lens

Timeline

Start date
2018-10-10
Primary completion
2019-01-18
Completion
2019-06-01
First posted
2018-10-29
Last updated
2020-10-01
Results posted
2020-10-01

Locations

6 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03722784. Inclusion in this directory is not an endorsement.